Hemostemix Inc (QB) (HMTXF) News

HMTXF...089...🥳...OTC partnering with a NAZ company sounds promising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc. (NASDAQ: AIFF) ("Firefly"), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders.

Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the "Phase 1").

https://www.otcmarkets.com/stock/HMTXF/news/Hemostemix-and-FireFly-Neurosciences-Brain-Network-Analytics-BNATM-Engage-to-Complete-Phase-1-Vascular-Dementia-Clinical?id=469780

Still following Hemostemix? I would be engaged for the short run up!
$1+

Looking like Hemostemix may be an emerging leader in the stem cell arena? Now the recent pr announced the lowest COGS cost of goods in the industry?
$1.+

Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.

Boom boom time